Business Wire

Celero Ventures Opens $25 Million Early-Stage Fund to Investors Backing the Next Generation of European Software Companies

1.7.2025 09:30:00 CEST | Business Wire | Press Release

Share

Celero Ventures, a new venture capital firm founded by experienced software operators Dave Wyatt and Nick Cochran, is now raising its debut $25 million fund to invest in early-stage startups across the UK and Europe. The fund, which is already 25% subscribed, targets pre-seed and seed-stage companies building next-generation AI and data infrastructure.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250701820933/en/

Nick Cochran and David Wyatt (right) Founders of Celero Ventures

Based in London, Celero Ventures is inviting limited partners (LPs) to join its mission of backing exceptional technical founders and accelerating their path to product-market fit and scalable growth.

Wyatt and Cochran bring a rare combination of deep go-to-market (GTM) experience and startup leadership. Together, they helped scale both MuleSoft and Databricks—two of the most successful enterprise software companies of the past decade. Their experience building and leading commercial teams across Europe and North America forms the foundation of Celero’s operator-first investment approach.

“Our goal is to give founders what we wish we’d had earlier in our careers: practical, experienced support from people who’ve built and scaled GTM from the ground up,” said Wyatt. “We’re raising this fund to support those teams early—when execution, speed, and strategic clarity matter most.”

The fund will invest in 20 to 25 companies, primarily across the UK and Europe, with an emphasis on AI, data tooling, and infrastructure software. Celero has already made its first investments, including leading a pre-seed round in a technical founding team building novel AI infrastructure.

Wyatt and Cochran have personally anchored the fund, reinforcing long-term alignment with both founders and investors.

“We’re not just investing capital—we’re investing capability,” said Cochran. “We work side by side with founders on segmentation, hiring, pricing, and repeatable growth playbooks—the kinds of things we’ve done at scale ourselves.”

One of Celero’s early portfolio companies, Catio, is already seeing that approach in action.

“Dave and Nick helped us get our GTM engine humming,” said Boris Bogatin, CEO of Catio. “They bring sharp insight, hands-on support, and a real sense of partnership. They’re the kind of investors you want when things are moving fast and stakes are high.”

Celero’s strategy is grounded in the belief that strong commercial execution is often the difference-maker in early-stage success—especially for technical founding teams. The fund is designed to close that gap by offering both capital and highly relevant operational support.

While the firm is headquartered in London, Celero is building a geographically diverse portfolio across Europe. Its focus is on founders building the infrastructure and applications that will define the AI-native enterprise stack.

Howard Dawber, Deputy Mayor of Business & Growth, said: “It’s great to see London reinforcing its position once more as a global leader in Tech, with London-based Celero Ventures expanding its investment in start-ups across the UK and Europe. This investment will be a game-changer for start-ups in their early stages, offering both funding and operational support at a critical time. Europe is home to incredible talent in the AI and data infrastructure space, and I look forward to seeing how Celero’s backing transforms companies beginning to make their mark in this industry.”

“Europe is home to world-class technical talent,” said Wyatt. “What many of those teams need is sharper, earlier GTM support. That’s what we’re bringing—and we’re looking for LPs who believe in the same opportunity.”

Janet Coyle CBE, Managing Director of Grow London at London & Partners said: "Here in the capital, investors and founders alike benefit from a unique blend of world‑leading talent, unrivalled market access and a quality of life that simply can’t be matched. From the energy of our tech communities to the global networks that span the City and Canary Wharf, London offers VCs and funds a gateway to Europe and beyond. It’s no surprise that more and more investors are calling London home. We look forward to working with Celero Ventures as they back the next generation of AI and infrastructure innovators right here in London.”

Celero Ventures is currently speaking with family offices, high-net-worth individuals, and institutional investors interested in partnering on the next wave of software innovation—alongside a team with deep operating experience and proven track records.

For more information on participating in the fund, visit celeroventures.com or contact the team directly.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250701820933/en/

Contacts

David Wyatt - David@celeroventures.com - +44 7979 542753

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers17.7.2026 19:10:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced that it will highlight data from several programs in its oncology portfolio in six presentations at the European Society of Medical Oncology (ESMO) Congress 2026, being held October 23 - 27, 2026, in Madrid. “The data at ESMO will further illustrate Incyte’s commitment to advancing innovation for patients with cancer,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "Among the presentations are important updates from our KRAS G12D inhibitor in advanced pancreatic cancer and colorectal cancer, our TGFβR2×PD-1 bispecific antibody in microsatellite stable colorectal cancer and our CDK2 inhibitor in recurrent epithelial ovarian cancer – investigational approaches that reflect our focus on areas where there is significant need for novel therapies." Details on key data presentations at ESMO include: Rapid Oral Presentations INCB161734 (KRAS G12D) Safety and Efficacy of Oral KRAS G12D Inhibitor INCB161734 as Mono

STL Expands Its Optical Connectivity Portfolio in the US with the CONCAT Solution17.7.2026 14:24:00 CEST | Press Release

STL Optical Connectivity NA, LLC, (STLOC), a U.S. subsidiary of STL (Sterlite Technologies Ltd.) [NSE: STLTECH], a leading connectivity solutions provider for AI-ready digital infrastructure, today announced that it launched its new advanced FTTH solution, CONCAT, after successfully completing field trials on the networks of one of the largest telecom service providers in the United States. Following successful field validation, CONCAT is now available to digital infrastructure providers seeking faster fiber rollouts with reduced deployment complexity and labor. It enables up to 71% in labor cost savings by eliminating most field splicing through factory-assembled, pre-connectorized fiber segments that deliver plug-and-play installation. CONCAT simplifies fiber deployment by shifting critical fiber preparation and termination into a controlled manufacturing environment ensuring consistent quality, faster installation, and lower operational risk in the field. CONCAT solution is ideal fo

Aqemia and Sanofi Expand Their Research Collaboration17.7.2026 12:30:00 CEST | Press Release

Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical company, Sanofi. The expansion is marked by the nomination of a new therapeutic target and an additional payment. The collaboration, first announced in December 2023, makes Aqemia eligible to receive up to a total of $140 million in upfront and milestone payments across programs. It spans the drug discovery journey from the identification of the very first hits to the selection of a development candidate. Aqemia leverages Qemi, its proprietary physics-based generative AI platform, to design novel molecules addressing Sanofi’s targets of choice, working in close collaboration with Sanofi scientific teams. Sanofi leads wet lab research, development and commercialization. The collaboration now runs across continents, between Aqemia researchers in Paris and London and San

China's ~$900B Live-Commerce Market Now Approaches US E-Commerce Scale17.7.2026 12:30:00 CEST | Press Release

The center of gravity in global retail has shifted East. The formats now driving the fastest growth in global retail (live shopping, social commerce, and delivery in minutes) were pioneered and scaled in Asia, and most Western consumers have yet to adopt them. According to NIQ (NYSE: NIQ), a leading consumer intelligence company, in its global report The Commerce Revolution: Where East Meets West, the gap between East and West is still vast. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717253489/en/ China´s USD 900bn live shopping boom now approaches the scale of the US E-commerce The scale is already substantial. China's live-commerce market alone was worth roughly $900 billion in 2025, approaching the size of the entire US e-commerce market, according to market data cited in the report. Yet 68% of consumers in North America and 67% in Europe have never once bought a product through social media, and roughly two-thirds

Ant International’s Alipay+ Connects Argentina's National QR Payment Scheme via PVS, Enabling for Cross-Border Digital Payment Nationwide at Millions of Merchants17.7.2026 12:17:00 CEST | Press Release

Alipay+, a global digital payment gateway under Ant International, today announced that it will enable global travellers to make QR code payments at millions of merchants across Argentina through integration with the country's national QR payment scheme Transferencias 3.0, in partnership with PVS, a fintech company specialized in developing customized payment solutions in Latin America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717276406/en/ By connecting to Argentina's national QR payment scheme, Alipay+ now enables global travellers in the country to make convenient QR code payments at merchants nationwide. This service helps to enhance global travellers' travel experiences in Argentina, allowing them to pay seamlessly at restaurants, malls and tourist attractions. Using an Alipay+ partner payment app, they can now scan the national QR code displayed at all merchants to make cross-border payments across Argentina,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye